Open AccessA retrospective analysis of efficacy and safety of intralesional triamcinolone injections in the treatment of frontal fibrosing alopecia either as monotherapy or as a concomitant therapy
Author(s) -
Maria-Angeliki Gkini,
Rumaisa Riaz,
Victoria Jolliffe
Publication year - 2018
Publication title -
international journal of trichology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.494
H-Index - 22
eISSN - 0974-9241
pISSN - 0974-7753
DOI - 10.4103/ijt.ijt_46_18
Subject(s) - concomitant , medicine , adverse effect , combination therapy , scalp , triamcinolone acetonide , dermatology , demographics , surgery , demography , sociology
Frontal fibrosing alopecia (FFA) is a primary cicatricial alopecia characterized by progressive recession of frontal, and often temporoparietal, hairline mainly in postmenopausal women. Currently, there are no guidelines or proposed evidence-based treatment for FFA.